NAD+ 1000mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of NAD+ supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF-NAD1000-B242

Key analytical results include:

• Assay Content: 1106 mg
• Identification – Retention Time: 0.993
• Identification – Spectrum: 1000
• Purity: 99.0 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency. :contentReference[oaicite:0]{index=0}

Product Overview

NAD+ is a coenzyme studied in controlled laboratory environments focused on cellular metabolism, redox reactions and biochemical signalling pathways.

The compound is widely investigated in biochemical research for its role in metabolic processes and intracellular energy systems.

This preparation contains 1000 mg of high purity lyophilized compound supplied in a sealed research vial. The lyophilization process preserves stability and allows precise reconstitution for controlled in vitro experimentation.

Due to its defined molecular structure and stable analytical profile, NAD+ is frequently referenced in experimental biochemical research models.

Compound Overview

NAD+ is a coenzyme studied in biochemical research for its interaction with metabolic pathways and cellular regulatory systems.

Within experimental models, it is commonly investigated for its involvement in redox reactions and intracellular signalling processes.

Because of its defined molecular profile, the compound is frequently used in laboratory studies examining metabolic regulation and biochemical pathways.

Historical Background and Scientific Context

Scientific interest in NAD+ has expanded significantly with advances in cellular biology and metabolic research.

The compound has been extensively studied for its role in energy metabolism and biochemical signalling in controlled laboratory environments.

This has enabled deeper investigation into molecular mechanisms and cellular regulatory systems.

Mechanistic Focus in Research

Within experimental laboratory settings, NAD+ is commonly studied in relation to metabolic and biochemical signalling pathways.

Research investigations commonly explore the compound in experimental models examining:

• Cellular metabolism pathways
• Redox reactions
• Intracellular signalling mechanisms
• Energy regulation systems
• Comparative biochemical research
• Molecular pathway analysis
• Cellular regulatory interactions

These experimental models allow scientists to investigate molecular mechanisms involved in metabolic and cellular processes.

Research Applications

In controlled research environments, NAD+ may be utilised in experimental models designed to explore cellular metabolism and biochemical signalling systems.

Examples of research applications include:

• Metabolic pathway investigation
• Redox reaction studies
• Intracellular signalling modelling
• Comparative biochemical studies
• Molecular pathway analysis
• Controlled in vitro research
• Laboratory metabolic studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Independently analysed by Liquilabs s.r.o. Czechia
• 99.0 % purity confirmed by COA
• Assay content verified at 1106 mg
• Endotoxin level below 0.001 EU/mg
• No detectable heavy metals or microbial contamination
• High-purity NAD+ compound for controlled laboratory research
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.